Partnership Opportunities
Why Partner?
Positioned at the intersection of innate immunity and clinical innovation, the 7th Myeloid-Directed Therapies Summit is the only industry-focused meeting exclusively dedicated to harnessing the therapeutic potential of macrophages, monocytes, dendritic cells, and neutrophils in oncology and chronic inflammation. Unlike broader IO or immunology events, this Summit unites a scientifically rigorous, high-intent audience specifically seeking myeloid-targeted tools, platforms, and preclinical models.
As a partner, this is your unmatched opportunity to get in front of clinical, translational, and R&D decision makers from top pharma and emerging biotechs, positioning your brand as the go-to solution in myeloid drug discovery and development.
Our Past Partners:
Experts Need Your Help With:
Next-generation in vitro and ex vivo models to better recapitulate the complexity of human myeloid biology and improve preclinical predictiveness
Spatial and multi-omics platforms that can precisely map myeloid heterogeneity, plasticity, and therapy-induced dynamics in the TME
Targeted delivery systems (e.g: nanoparticles, ASOs, LNPs) that enable cell-type-specific modulation of myeloid populations without off-target toxicity
Robust, clinically validated biomarker platforms for myeloid-directed patient stratification and real-time monitoring of therapeutic response
... And much more!
Reasons to Partner With The Summit:
Showcase your scientific innovation to a focused, influential audience advancing myeloid cell reprogramming, engineering, and targeting in oncology and inflammation
Establish thought leadership and elevate your brand alongside AbbVie, Pfizer, AstraZeneca, and leading academics by sponsoring or presenting key content in translational, clinical, and biomarker-driven sessions
Boost brand credibility and visibility as a trusted partner for biopharma and biotech teams in the myeloid space seeking cutting-edge diagnostics, precision imaging, and scalable therapeutic monitoring solutions
Gain exclusive insight into key R&D challenges - target validation, model limitations, patient stratification, and delivery - to better understand your market and refine your value proposition
Access curated networking and 1-to-1 introductions with biotech and pharma leaders seeking collaborators in spatial biology, CAR-M, siRNA delivery, and advanced omics